Global
English
Global
English
Poland
polski
Czechia
Český
Italy
Italiano
Kazakhstan
Қазақ
Slovakia
Slovenský
Spain
Español
Ukraine
Українськa
Uzbekistan
Ўзбекча
Vietnam
Tiếng việt
x
Information on results of RFP - 025130 - IN VIVO ANTI-CANCER EFFICACY STUDY USING MATERIAL FROM DONORS
In connection with the project „Clinical trial of the first phase (Ia/Ib) of a fusion protein with a dual anticancer mechanism”, financed from Medical Research Agency (nr. 2022/ABM/05/00006-00) operating under §8 of the subsidy agreement, Adamed Pharma informs that due to project’s reasons, RFP was canceled.